Skip to main content

Table 5 Impact of rehabilitation programme on respiratory symptoms and quality of life - including only participants MRC > =3

From: Is a large scale community programme as effective as a community rehabilitation programme delivered in the setting of a clinical trial?

 

Randomised trial – community setting intervention group

BreathingSpace – participants MRC > =3Mean after-before difference

  
 

n

Mean before-after difference

SD

n

Mean before-after difference

SD

Difference in mean before-after differences (95% CI)

P-value for difference in mean before-after differences

CRQ symptoms

        

Dyspnoea

74

0.29

1.18

329

0.55

1.20

0.26 (−0.04, 0.56)

0.09

Fatigue

75

0.58

1.12

329

0.51

1.21

−0.07 (−0.36, 0.21)

0.61

Emotion

74

0.39

0.98

329

0.34

1.15

−0.05 (−0.31, 0.21)

0.70

Mastery

75

0.36

1.08

329

0.27

1.24

−0.09 (−0.37, 0.19)

0.53

SF-36v2 domains

        

Physical functioning

79

0.87

17.6

333

5.81

20.4

4.94 (0.36, 9.53)

0.03*

Role-physical

79

8.25

24.6

331

7.30

27.0

−0.95 (−7.27, 5.36)

0.77

Bodily pain

78

1.29

25.8

277

2.93

26.3

1.64 (−5.07, 8.35)

0.63

General health

77

3.93

15.7

263

3.17

17.0

−0.76 (−4.94, 3.42)

0.72

Vitality

79

8.15

16.8

269

7.59

21.4

−0.55 (−5.18, 4.08)

0.81

Social functioning

80

12.7

29.5

277

8.35

32.7

−4.31 (−12.04, 3.42)

0.27

Role-emotional

79

5.17

31.0

268

7.91

34.8

2.74 (−5.44, 10.93)

0.51

Mental health

80

5.81

15.7

274

4.76

19.5

−1.05 (−5.31, 3.20)

0.62

PCS (Physical component summary)

73

0.98

6.49

249

1.31

7.76

0.33 (−1.48, 2.13)

0.72

MCS (Mental component summary)

73

5.38

10.4

249

3.95

12.8

−1.43 (−4.35, 1.49)

0.34

SF-6D

72

0.014

0.10

245

0.030

0.11

0.016 (−0.010, 0.043)

0.23

EQ-5D-3 L

80

0.066

0.28

249

0.044

0.15

−0.022 (−0.086, 0.042)

0.51

  1. * significant at 5% level.